A Study of MIcrocirculatory Perfusion Alterations in Severe Burn Injury
NCT ID: NCT04500197
Last Updated: 2020-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
21 participants
OBSERVATIONAL
2018-11-12
2020-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary objectives are to assess differences in microcirculatory perfusion alterations between early (\<12 hours post burn injury) and late standard resuscitation (\>12 hours post burn injury) with addition of albumin to the regime.
And to measure several biomarkers of glycocalyx shedding, oxidative stress and inflammation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Sublingual Microcirculation in Burn During Resuscitation
NCT05096559
Cardiovascular Responses in Burn Survivors During Exercise
NCT06709781
Microcirculatory Perfusion in Patients With Coma After Out-of-hospital Cardiac Arrest
NCT01850485
Skin Wetting in Burn Survivors
NCT06529757
Microcirculatory Assessment in Patients With Trauma and Severe Burns
NCT01922960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study design: Single-center, prospective, observational clinical study in the Maasstad Hospital.
Study population: All adult patients who are admitted to the Intensive Care Unit with severe burns over 15%TBSA and resuscitated with the standard resuscitation protocol will be included.
Main study parameters/endpoints: Measurement of sublingual microcirculation with vessel density and flow parameters. Also skin perfusion maps (Laser Speckle Imaging) will be recorded. Blood and urine samples will also be used for measuring glycocalyx shedding products.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness:
Microcirculation assessment and laser speckle imaging are non-invasive procedures, and there are negligible risks. Blood tests will be used for measuring glycocalyx shedding products, this is an invasive procedure which may increase the risk of contamination, patient discomfort and in some extreme cases blood sample collection may be a burden on patient haemoglobin levels which is prone to decrease in critical patients. Assessment is essential for determining whether action is required to change our existing resuscitation regime for critically ill burned patients. If the results show that the current resuscitation regime is suboptimal, then motivation for changing the existing practice can lead to improved clinical care and a reduction in over- or under resuscitation in the ICU environment with its potential harmful effects.
The risks associated with participation can be considered negligible and the burden can be considered minimal in this observational study. The patients taking part in this study will have no direct benefit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ≥ 18 years of age
3. Receiving standard resuscitation protocol for severe burn injury
4. Post burn time up to a maximum of 24 hours
Exclusion Criteria
2. (suspected) generalised infection
3. Other traumatic injury, which is supposed to generate a systemic inflammatory response eg severe fractures, or other types of shock as a result of massive bleeding
4. Patients unlikely to survive \>24 hours
5. Decision not to initiate treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maasstad Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Can Ince, Prof
Role: STUDY_DIRECTOR
Erasmus Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maasstad Hospital
Rotterdam, Zuid Nederland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L2015126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.